Serial Prediction of Death or Neurodevelopmental Impairment in Extremely Preterm Infants

Monday, April 25, 2022

2:00 PM – 2:15 PM US MT

Location: Convention Center: Mile High Ballroom 4AB

CE: Enduring CME: 0.25

Publication Number: 3580.5

Neha Kumbhat, Stanford University School of Medicine, San Diego, CA, United States; Barry S. Eggleston, RTI International, Mebane, NC, United States; Matthew Rysavy, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, United States; Noelle Younge, Duke University School of Medicine, Durham, NC, United States; Vivek V. Shukla, University of Alabama at Birmingham, Birmingham, AL, United States; Waldemar A. Carlo, University of Alabama at Birmingham, Birmingham, AL, United States; Edward F. Bell, University of Iowa Roy J. and Lucille A. Carver College of Medicine, Iowa City, IA, United States; Ravi M. Patel, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, United States; Betty R. Vohr, Women & Infants Hospital of Rhode Island; Alpert Medical School of Brown University, Providence, SD, United States; Susan R. Hintz, Stanford University School of Medicine, Palo Alto, CA, United States; Krisa P. Van Meurs, Stanford University School of Medicine, Palo Alto, CA, United States; Abhik Das, RTI International, North Potomac, MD, United States; Namasivayam Ambalavanan, University of Alabama School of Medicine, Birmingham, AL, United States; NICHD Neonatal Research Network, NICHD, Bethesda, MD, United States

Presenting Author(s)

Neha Kumbhat, MD, MSEpi
Assistant Professor
Stanford University School of Medicine
San Diego, California, United States

Full Presentation

Participants should be aware of the following financial/non-financial relationships:

Neha Kumbhat, MD, MSEpi: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Barry S. Eggleston, M.S.: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Matthew A. Rysavy, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Noelle Younge, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Vivek V. Shukla, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Waldemar A. Carlo, MD: ● Mednax (Currently Ongoing) (Products/Services: Board Member or Executive Role, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).

Edward F. Bell, M.D.: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Ravi M. Patel, MD, MSc: ● Infant Bacterial Therapeutics / Premier Research (Currently Ongoing) (Products/Services: Consultant).

Betty R. Vohr, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Susan R. Hintz, MD, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Krisa P. Van Meurs, M.D.: ● Greenwich Biosciences (Products/Services: Advisory Committee).

Abhik Das, Ph.D.: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Namasivayam Ambalavanan, MBBS MD: ● ProvePharm (Currently Ongoing) (Products/Services: Consultant).
● Radiometer (Currently Ongoing) (Products/Services: Consultant).
● ResBiotic (Currently Ongoing) (Products/Services: Advisory Committee).
● Shire (Currently Ongoing) (Products/Services: Consultant).

NICHD Neonatal Research Network: I do not have any relevant financial / non-financial relationships with any proprietary interests.